Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial
- Citation:
- Int J Radiat Oncol Biol Phys vol 103 (3) 686-96
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Portions of the results of this prospective trial were presented at the International Association for the Study of Lung Cancer 18th World Conference on Lung Cancer, Yokohama, Japan, October 15-18, 2017.
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2764
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- UUG1CA189823, U10CA180790
- Corr. Author:
- Authors:
- Terence T. Sio Pamela J. Atherton Levi D. Pederson W. Ken Zhen Robert W. Mutter Yolanda I. Garces Daniel J. Ma James L. Leenstra Jean-Claude M. Rwigema Shaker Dakhil James D. Bearden Sonja J. van der Veen Apar K. Ganti Steven E. Schild Robert C. Miller
- Networks:
- KS055, LAPS-MN026, NE003, UPSTATE
- Study
- MC1221
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: